A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type  2 Diabetes in Clinical Practice: The JAGUAR Study

ConclusionSwitching from insulin to IDegAsp co-formulation was associated with significantly improved glycemic control and a reduction in hypoglycemia rate during 12  months of follow-up in Japanese patients with T2D, including those aged >  75 years.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research